Trial Profile
Effect of short term rifaximin treatment in cirrhotic patients with minimal hepatic encephalopathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Hepatic encephalopathy; Liver cirrhosis
- Focus Therapeutic Use
- 11 Dec 2015 New trial record